Will India Get Monoclonal Antibodies After Serum India's Agreement With Merck?

  • 20:30
  • Published On: October 23, 2020
Cinema View
Embed
Donald Trump called monoclonal antibodies the 'cure' as he recovered from Covid after being administered a cocktail of them. Now Serum India has signed a deal with pharmaceutical company Merck and a non-profit organisation to ensure this expensive treatment is accessible globally, even in low income countries. Does that mean it will be available in India in the future?

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
"A Very Big Source Of Covid Vaccines For World": Bill Gates Praises India
February 29, 2024 3:21
'Poverty Associated With Long Covid': Dr Soumya Swaminathan
February 19, 2024 6:52
What Does Covid-19 Do To Your Lungs?
February 19, 2024 22:46
"This Was Expected": Karnataka Health Minister On JN.1 Cases In State
December 25, 2023 3:57
Maharashtra Reports 50 New COVID-19 Cases, 9 Of Them JN.1 Infections
December 25, 2023 0:46
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination